Sarit Polsky
Endocrinology, Diabetes & Metabolism · Aurora, CONPI 1689862641
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $5,413 and has fallen 52.5% since, to $2,570 in 2025.
Across 44 payments — averaging $221.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Insulet Corporation$2K
- Dexcom, Inc.$559
- Tandem Diabetes Care, Inc.$550
- Abbott$451
- Corcept Therapeutics$144
- plus $46 from 1 others
Across 23 payments — averaging $25,412 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dexcom, Inc.$366K
- Medtronic$219K
What the payments were for
- Consulting fees$4,50046%
- Speaking & faculty fees$8509%
- Grants$571%
- Travel & lodging$2,13022%
- Food & beverage$2,18923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $5,855 |
| Insulet Corporation | 11 | $2,120 |
| Dexcom, Inc. | 7 | $559 |
| Tandem Diabetes Care, Inc. | 2 | $550 |
| Abbott | 3 | $451 |
| Corcept Therapeutics | 1 | $144 |
| Boehringer Ingelheim | 1 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$1,901
- Minimed 670G System$628
- t-slim insulin pump$550
- FreeStyle Libre$300
- DEXCOM G6 TRANSMITTER$283
- MINIMED 780G$167
- DEXCOM G7 GSS (161)$149
- Korlym$144
How this compares
$9,726 in reported general payments places this provider in the 80th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 16 | $20,088 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $16,762 |
| HumalogInsulin Lispro | 14 | $4,653 |
| NovologInsulin Aspart | 12 | $3,767 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $3,132 |
| Rosuvastatin Calcium | 14 | $231 |
| Levothyroxine Sodium | 23 | $195 |
| Metformin Hcl | 19 | $110 |
| Atorvastatin Calcium | 14 | $53 |
| Losartan Potassium | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Aurora
- Satish GargAurora$347K
- Viralkumar ShahAurora$256K
- Neda RasouliAurora$188K
- Halis AkturkAurora$109K
- Robert EckelAurora$66K
- Marc Andre CornierAurora$62K
- Jane ReuschAurora$59K
- James FalkoAurora$45K
- Aaron MichelsAurora$37K
- Margaret WiermanAurora$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.